7QGW | pdb_00007qgw

Sulfonated Calpeptin is a promising drug candidate against SARS-CoV-2 infections


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.30 Å
  • R-Value Free: 
    0.196 (Depositor), 0.174 (DCC) 
  • R-Value Work: 
    0.172 (Depositor) 
  • R-Value Observed: 
    0.172 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 7QGW

Ligand Structure Quality Assessment 


This is version 1.3 of the entry. See complete history

Literature

Calpeptin is a potent cathepsin inhibitor and drug candidate for SARS-CoV-2 infections.

Reinke, P.Y.A.de Souza, E.E.Gunther, S.Falke, S.Lieske, J.Ewert, W.Loboda, J.Herrmann, A.Rahmani Mashhour, A.Karnicar, K.Usenik, A.Lindic, N.Sekirnik, A.Botosso, V.F.Santelli, G.M.M.Kapronezai, J.de Araujo, M.V.Silva-Pereira, T.T.Filho, A.F.S.Tavares, M.S.Florez-Alvarez, L.de Oliveira, D.B.L.Durigon, E.L.Giaretta, P.R.Heinemann, M.B.Hauser, M.Seychell, B.Bohler, H.Rut, W.Drag, M.Beck, T.Cox, R.Chapman, H.N.Betzel, C.Brehm, W.Hinrichs, W.Ebert, G.Latham, S.L.Guimaraes, A.M.S.Turk, D.Wrenger, C.Meents, A.

(2023) Commun Biol 6: 1058-1058

  • DOI: https://doi.org/10.1038/s42003-023-05317-9
  • Primary Citation Related Structures: 
    7QGW, 7QKA, 7QKB, 7QKC, 7Z3T, 7Z3U, 7Z58, 8C3D

  • PubMed Abstract: 

    Several drug screening campaigns identified Calpeptin as a drug candidate against SARS-CoV-2. Initially reported to target the viral main protease (M pro ), its moderate activity in M pro inhibition assays hints at a second target. Indeed, we show that Calpeptin is an extremely potent cysteine cathepsin inhibitor, a finding additionally supported by X-ray crystallography. Cell infection assays proved Calpeptin's efficacy against SARS-CoV-2. Treatment of SARS-CoV-2-infected Golden Syrian hamsters with sulfonated Calpeptin at a dose of 1 mg/kg body weight reduces the viral load in the trachea. Despite a higher risk of side effects, an intrinsic advantage in targeting host proteins is their mutational stability in contrast to highly mutable viral targets. Here we show that the inhibition of cathepsins, a protein family of the host organism, by calpeptin is a promising approach for the treatment of SARS-CoV-2 and potentially other viral infections.


  • Organizational Affiliation
    • Center for Free-Electron Laser Science CFEL, Deutsches Elektronen-Synchrotron DESY, Notkestr. 85, 22607, Hamburg, Germany.

Macromolecule Content 

  • Total Structure Weight: 50.19 kDa 
  • Atom Count: 4,293 
  • Modeled Residue Count: 442 
  • Deposited Residue Count: 442 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Cathepsin L2
A, B
221Homo sapiensMutation(s): 2 
Gene Names: CTSVCATL2CTSL2CTSUUNQ268/PRO305
EC: 3.4.22.43
UniProt & NIH Common Fund Data Resources
Find proteins for O60911 (Homo sapiens)
Explore O60911 
Go to UniProtKB:  O60911
PHAROS:  O60911
GTEx:  ENSG00000136943 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupO60911
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
RN2

Query on RN2



Download:Ideal Coordinates CCD File
K [auth A],
U [auth B]
Calpeptin
C20 H32 N2 O4
JDNZSBPOIODDLU-ROUUACIJSA-N
MPD

Query on MPD



Download:Ideal Coordinates CCD File
F [auth A],
J [auth A],
L [auth B],
O [auth B],
S [auth B]
(4S)-2-METHYL-2,4-PENTANEDIOL
C6 H14 O2
SVTBMSDMJJWYQN-YFKPBYRVSA-N
GOL

Query on GOL



Download:Ideal Coordinates CCD File
G [auth A]
I [auth A]
N [auth B]
P [auth B]
Q [auth B]
G [auth A],
I [auth A],
N [auth B],
P [auth B],
Q [auth B],
T [auth B]
GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N
CL

Query on CL



Download:Ideal Coordinates CCD File
C [auth A]
D [auth A]
E [auth A]
H [auth A]
M [auth B]
C [auth A],
D [auth A],
E [auth A],
H [auth A],
M [auth B],
R [auth B]
CHLORIDE ION
Cl
VEXZGXHMUGYJMC-UHFFFAOYSA-M

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.30 Å
  • R-Value Free:  0.196 (Depositor), 0.174 (DCC) 
  • R-Value Work:  0.172 (Depositor) 
  • R-Value Observed: 0.172 (Depositor) 
Space Group: P 43 21 2
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 94.24α = 90
b = 94.24β = 90
c = 126.96γ = 90
Software Package:
Software NamePurpose
MAINrefinement
XDSdata reduction
Aimlessdata scaling
MOLREPphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Slovenian Research AgencySlovenia--

Revision History  (Full details and data files)

  • Version 1.0: 2022-12-21
    Type: Initial release
  • Version 1.1: 2023-11-01
    Changes: Data collection, Database references
  • Version 1.2: 2024-01-31
    Changes: Refinement description
  • Version 1.3: 2024-10-23
    Changes: Structure summary